瘤内T细胞对滤泡性淋巴瘤FDG-PET参数的不同影响
滤泡性淋巴瘤(FL)治疗前FDG-PET的预后价值存在矛盾。本研究评估治疗前FDG-PET参数并用多种方法量化瘤内T细胞,发现低瘤内T细胞与约六倍高的总代谢肿瘤体积(TMTV)相关,而SUVmax与T细胞相关而非B细胞。TMTV最好反映恶性B细胞负荷,瘤内T细胞影响SUVmax,这可能解释不同FDG-PET参数预后作用的矛盾结果。
要点
- 低瘤内T细胞与约六倍高的TMTV相关。
- 高TMTV的FL淋巴结恶性B细胞浸润增加且克隆扩增的瘤内CD8+和CD4+ T滤泡辅助细胞减少。
- SUVmax与T细胞相关而非B细胞,TMTV最好反映恶性B细胞负荷。
核心结论
- TMTV最好反映FL的恶性B细胞负荷,而瘤内T细胞影响SUVmax。
- 瘤内T细胞的葡萄糖摄取可能解释不同FDG-PET参数预后作用的矛盾结果。
研究设计与样本
- 评估治疗前FDG-PET参数并用多种方法量化瘤内T细胞。
主要发现
- 低瘤内T细胞与约六倍高的TMTV相关。
- 高TMTV的FL淋巴结显示恶性B细胞浸润增加且克隆扩增的瘤内CD8+和CD4+ T滤泡辅助细胞减少。
- CD4+和CD8+ T细胞的荧光标记葡萄糖摄取高于瘤内B细胞。
- 在切除活检前进行FDG-PET的患者中,后续切除淋巴结内的SUVmax与T细胞相关而非B细胞。
临床怎么用
- 解读FL治疗前FDG-PET时应考虑瘤内T细胞葡萄糖摄取的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Data on the prognostic impact of pretherapy 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) in follicular lymphoma (FL) is conflicting. The predictive utility of pretherapy total metabolic tumor volume (TMTV) and maximum standardized uptake value (SUVmax) on outcome appears to vary between regimens. Chemoimmunotherapies vary in the extent of T-cell depletion they induce. The role of intratumoral T cells on pretherapy FDG-PET parameters is undefined. We assessed pretherapy FDG-PET parameters and quantified intratumoral T cells by multiple methodologies. Low intratumoral T cells associated with approximately sixfold higher TMTV, and FL nodes from patients with high TMTV showed increased malignant B-cell infiltration and fewer clonally expanded intratumoral CD8+ and CD4+ T-follicular helper cells than those with low TMTV. However, fluorescently labeled glucose uptake was higher in CD4+ and CD8+ T cells than intratumoral B cells. In patients with FDG-PET performed prior to excisional biopsy, SUVmax within the subsequently excised node associated with T cells but not B cells. In summary, TMTV best reflects the malignant B-cell burden in FL, whereas intratumoral T cells influence SUVmax. This may contribute to the contradictory results between the prognostic role of different FDG-PET parameters, particularly between short- and long-term T-cell-depleting chemoimmunotherapeutic regimens. The impact of glucose uptake in intratumoral T cells should be considered when interpreting pretherapy FDG-PET in FL.
引用
- Nath K, Law SC, Sabdia MB, et al. Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma. Blood Adv. 2021. PMID: 34156439. doi:10.1182/bloodadvances.2020004051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。